A Retroperitoneal Hematoma in a Patient on Anticoagulants
Keywords:
Spontaneous retroperitoneal haemorrhage (SRH), Anticoagulant, Abdominal aortic aneurysmAbstract
Aim
Spontaneous retroperitoneal haemorrhage (SRH), a potentially fatal complication with an atypical presentation, is caused by anticoagulants. The present body of literature does not offer much guidance for diagnosing and treating these situations. This case report’s major goal is to give a general review of the condition’s clinical presentation and anticoagulant therapy in relation to spontaneous retroperitoneal haemorrhage.
Case report
In this case report, we have covered an instance of retroperitoneal bleeding brought on by anticoagulants. Due to abdominal pain, a computed tomography (CT) scan of the abdomen was performed on the patient, who was using an anticoagulant, and it diagnosed a retroperitoneal hematoma.
Conclusion
Spontaneous retroperitoneal bleeding is an uncommon occurrence. When patients taking anticoagulant medications appear with stomach pain and distension, retroperitoneal haemorrhage should always be considered a possibility. With this presentation, this is one such instance. An early diagnosis will aid in the proper treatment of the patient.
References
Sunga KL, Bellolio MF, Gilmore RM, Cabrera D. Spontaneous retroperitoneal hematoma: Etiology, characteristics, management, and outcome. J Emerg Med. 2012; 43(2): e157-e161. doi: 10.1016/j. jemermed.2011.06.006
Bhasin HK, Dana CL. Spontaneous retroperitoneal hemorrhage in chronically hemodialyzed patients. Nephron. 1978; 22: 322-327. doi: 10.1159/000181470
Kalinowski EA, Trerotola SO. Postcatheterization retroperi-toneal hematoma due to spontaneous lumbar arterial hemor-rhage. Cardiovasc Intervent Radiol. 1998; 21: 337-339. doi: 10.1007/ s002709900272 Intern Med Open J. 2025; 9(1): 6-8.
Palleja XE, Domingo P, Fontcuberta J, Felez J. Spontane-ous retroperitoneal hemorrhage during oral anticoagulant therapy. Arch Intern Med. 1985; 145: 1531-1534. doi: 10.1001/ archinte.1985.00360080213039
Mant MJ, O’Brien BD, Thong KL, et al. Haemorrhagic com-plications of heparin therapy. Lancet. 1977; 1: 1133-1135. doi: 10.1016/s0140-6736(77)92388-1
Forfar JC. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. Br Heart J. 1979; 42: 128-132. doi: 10.1136/hrt.42.2.128
Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialy-sis patients. J Am Soc Nephrol. 2009; 20(4): 872-881. doi: 10.1681/ ASN.2008080824
Ohgushi A, Ohtani T, Nakayama N, et al. Risk of major bleed-Submit your article to this journal | https://openventio.org/submit-manuscript/ Rajasekar R, et al ing at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: A nested case-control study. J Pharm Health Care Sci. 2016; 2: 2. doi: 10.1186/ s40780-015-0036-1
Simeone JF, Robinson F, Rothman SLG, Jaffe C. Computerised tomographic demonstration of a retroperitoneal haematoma caus-ing femoral neuropathy: Report of two cases. J Neurosurg. 1977; 47: 946-948. doi: 10.3171/jns.1977.47.6.0946
Butterfield WC, Neviaser RJ, Roberts MP. Femoral neu-ropathy and anticoagulants. Ann Surg. 1972; 176: 58-61. doi: 10.1097/00000658-197207000-00012
Tran HA, Chunilal SD, Harper PL, et al. An update of con-sensus guidelines for warfarin reversal. Med J Aust. 2013; 198(4): 198-199. doi: 10.5694/mja12.10614
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Internal Medicine (IMOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
